Peter C. Johnson
Amministratore Delegato presso Scintellix LLC
Profilo
Peter C.
Johnson is the founder of Scintellix LLC, a company founded in 2005, where he holds the title of President & Chief Executive Officer since 2011.
He is also the founder of TissueInformatics, Inc. Dr. Johnson's current jobs include being a Director at Plakous Therapeutics, Inc. and a Director at Apie Therapeutics, Inc. Dr. Johnson's former jobs include being the Chief Medical Officer at Cogenics Icoria, Inc., the President at EADevices, Inc., the Chief Business Officer & Executive Vice President at Entegrion, Inc., and an Operations Advisor at Jenken Biosciences, Inc. Dr. Johnson's education includes an undergraduate degree from the University of Notre Dame and a doctorate degree from The State University of New York.
Posizioni attive di Peter C. Johnson
Società | Posizione | Inizio |
---|---|---|
Scintellix LLC | Amministratore Delegato | 17/09/2009 |
Apie Therapeutics, Inc.
Apie Therapeutics, Inc. Medical/Nursing ServicesHealth Services Apie Therapeutics, Inc. provides healthcare services. The private company is based in Durham, NC. The company was founded by Esther M. Alegria. Ashwin Datt has been the CEO of the company since 2023. | Direttore/Membro del Consiglio | - |
Plakous Therapeutics, Inc.
Plakous Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Plakous Therapeutics, Inc. is a human biologics company. The company was founded by Scott A. Washburn and Seth Tomblyn in 2016 and is headquartered in Winston-Salem, NC. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Peter C. Johnson
Società | Posizione | Fine |
---|---|---|
Cogenics Icoria, Inc.
Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Direttore Tecnico/Scientifico/R&S | 24/03/2005 |
TissueInformatics, Inc.
TissueInformatics, Inc. Packaged SoftwareTechnology Services TissueInformatics, Inc. engages in the development and application of TissueAnalytics, automated pathology software. It develops automated pathology software for the quantitative analysis of tissue changes in drug discovery, disease assessment, toxicology, and tissue engineering. The company is headquartered in Pittsburgh, PA. | Fondatore | - |
Jenken Biosciences, Inc.
Jenken Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Jenken Biosciences, Inc. operated as a pharmaceutical company. It specialized in the development and commercialization of small molecules as toll-like receptor 4 (TLR4) antagonists. The company was founded by Edwin Wu in 2003 and was headquartered in Durham, NC. | Corporate Officer/Principal | - |
Entegrion, Inc.
Entegrion, Inc. Pharmaceuticals: MajorHealth Technology Entegrion, Inc. develops biological technologies, drugs, and pharmaceuticals. It applies public and private funds to design, develop, and deliver products that address unmet needs in military healthcare and have commercial applications. The company was founded by Arthur P. Bode in 2002 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
EADevices, Inc.
EADevices, Inc. Electronic Equipment/InstrumentsElectronic Technology EADevices, Inc. develops minimally invasive surgical and related procedures and products. The company was founded by Joshua A. Gerlick in 2004 and is headquartered in Munhall, PA. | Presidente | - |
Formazione di Peter C. Johnson
University of Notre Dame | Undergraduate Degree |
The State University of New York | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 8 |
---|---|
Cogenics Icoria, Inc.
Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Commercial Services |
TissueInformatics, Inc.
TissueInformatics, Inc. Packaged SoftwareTechnology Services TissueInformatics, Inc. engages in the development and application of TissueAnalytics, automated pathology software. It develops automated pathology software for the quantitative analysis of tissue changes in drug discovery, disease assessment, toxicology, and tissue engineering. The company is headquartered in Pittsburgh, PA. | Technology Services |
EADevices, Inc.
EADevices, Inc. Electronic Equipment/InstrumentsElectronic Technology EADevices, Inc. develops minimally invasive surgical and related procedures and products. The company was founded by Joshua A. Gerlick in 2004 and is headquartered in Munhall, PA. | Electronic Technology |
Entegrion, Inc.
Entegrion, Inc. Pharmaceuticals: MajorHealth Technology Entegrion, Inc. develops biological technologies, drugs, and pharmaceuticals. It applies public and private funds to design, develop, and deliver products that address unmet needs in military healthcare and have commercial applications. The company was founded by Arthur P. Bode in 2002 and is headquartered in Durham, NC. | Health Technology |
Jenken Biosciences, Inc.
Jenken Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Jenken Biosciences, Inc. operated as a pharmaceutical company. It specialized in the development and commercialization of small molecules as toll-like receptor 4 (TLR4) antagonists. The company was founded by Edwin Wu in 2003 and was headquartered in Durham, NC. | Health Technology |
Scintellix LLC | |
Plakous Therapeutics, Inc.
Plakous Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Plakous Therapeutics, Inc. is a human biologics company. The company was founded by Scott A. Washburn and Seth Tomblyn in 2016 and is headquartered in Winston-Salem, NC. | Commercial Services |
Apie Therapeutics, Inc.
Apie Therapeutics, Inc. Medical/Nursing ServicesHealth Services Apie Therapeutics, Inc. provides healthcare services. The private company is based in Durham, NC. The company was founded by Esther M. Alegria. Ashwin Datt has been the CEO of the company since 2023. | Health Services |
- Borsa valori
- Insiders
- Peter C. Johnson